Histrelin acetate subcutaneous implant - Endo Pharmaceuticals Solutions

Drug Profile

Histrelin acetate subcutaneous implant - Endo Pharmaceuticals Solutions

Alternative Names: Histrelin implant; LHRH-Hydrogel implant; RL 0903; SPD 424; Supprelin-LA; Vantas; VP 002

Latest Information Update: 24 Mar 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Valera Pharmaceuticals
  • Developer BioPro Pharmaceutical; Endo International; Endo Pharmaceuticals Solutions; Teva-Tuteur; Valera Pharmaceuticals
  • Class Antineoplastics; Pituitary hormone releasing hormones
  • Mechanism of Action Gonadotropin releasing hormone stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Precocious puberty
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Precocious puberty; Prostate cancer

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 28 Feb 2014 Endo Health Solutions and Paladin Labs combine to form Endo International
  • 23 Mar 2012 No development reported - Preregistration for Prostate cancer in China (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top